FindTrial
Sign In

Evaluation of use of human donor skin grafts in treating burn wounds.

Evaluation of efficacy of human skin allografts in healing of partial thickness burn wounds.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030558
Enrollment
30
Registered
2021-01-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T300- Burn of unspecified body region, unspecified degree

Interventions

None listed

Sponsors

Dr Annappa Kudva
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Partial thickness burns undergoing tangential excision (Debridement) and allografting of burn wounds after hemodynamic stability in the department of Plastic Surgery

Exclusion criteria

Exclusion criteria: 1)Patients on Medications negatively affecting wound healing such as Corticosteroids, Chemotherapeutic agents. 2)Age > 75years, 3)Chemical induced Burns, Radiation Burns, Cold Burns, Immunocompromised patients and patient with collagen disorders.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of human skin allograft in the wound healing of partial thickness burn wounds as a definitive dressing. Wound is considered healing based on either of the following criteria 1.Peeling of allograft with evidence of epithelization of surface underneath. 2.Grafted area appears dry or the secretions from the grafted area are decreased when inspected on POD 4, POD 10, POD 15 and POD 21. Timepoint: Upto POD 21—

Secondary

MeasureTime frame
Allograft rejection and scarTimepoint: Upto 3 months after allograft application—

Countries

India

Contacts

Public ContactDr Annappa Kudva

Kasturba Medical College Manipal

ncs.kumar@manipal.edu9809353454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026